Microcirculatory dysfunction and dead-space ventilation in early ARDS: a hypothesis-generating observational study
verfasst von:
Gustavo A. Ospina-Tascón, Diego F. Bautista, Humberto J. Madriñán, Juan D. Valencia, William F. Bermúdez, Edgardo Quiñones, Luis Eduardo Calderón-Tapia, Glenn Hernandez, Alejandro Bruhn, Daniel De Backer
Ventilation/perfusion inequalities impair gas exchange in acute respiratory distress syndrome (ARDS). Although increased dead-space ventilation (VD/VT) has been described in ARDS, its mechanism is not clearly understood. We sought to evaluate the relationships between dynamic variations in VD/VT and extra-pulmonary microcirculatory blood flow detected at sublingual mucosa hypothesizing that an altered microcirculation, which is a generalized phenomenon during severe inflammatory conditions, could influence ventilation/perfusion mismatching manifested by increases in VD/VT fraction during early stages of ARDS.
Methods
Forty-two consecutive patients with early moderate and severe ARDS were included. PEEP was set targeting the best respiratory-system compliance after a PEEP-decremental recruitment maneuver. After 60 min of stabilization, hemodynamics and respiratory mechanics were recorded and blood gases collected. VD/VT was calculated from the CO2 production (\(V_{{{\text{CO}}_{2} }}\)) and CO2 exhaled fraction (\(F_{{{\text{ECO}}_{2} }}\)) measurements by volumetric capnography. Sublingual microcirculatory images were simultaneously acquired using a sidestream dark-field device for an ulterior blinded semi-quantitative analysis. All measurements were repeated 24 h after.
Results
Percentage of small vessels perfused (PPV) and microcirculatory flow index (MFI) were inverse and significantly related to VD/VT at baseline (Spearman’s rho = − 0.76 and − 0.63, p < 0.001; R2 = 0.63, and 0.48, p < 0.001, respectively) and 24 h after (Spearman’s rho = − 0.71, and − 0.65; p < 0.001; R2 = 0.66 and 0.60, p < 0.001, respectively). Other respiratory, macro-hemodynamic and oxygenation parameters did not correlate with VD/VT. Variations in PPV between baseline and 24 h were inverse and significantly related to simultaneous changes in VD/VT (Spearman’s rho = − 0.66, p < 0.001; R2 = 0.67, p < 0.001).
Conclusion
Increased heterogeneity of microcirculatory blood flow evaluated at sublingual mucosa seems to be related to increases in VD/VT, while respiratory mechanics and oxygenation parameters do not. Whether there is a cause–effect relationship between microcirculatory dysfunction and dead-space ventilation in ARDS should be addressed in future research.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ARDS
Acute respiratory distress syndrome
CO2
Carbon dioxide
COPD
Chronic obstructive pulmonary disease
CRS
Compliance of the respiratory system
EtCO2
End-tidal CO2
FCD
Functional capillary density
\(F_{{{\text{ECO}}_{2} }}\)
Exhaled CO2 fraction
MFI
Microcirculatory flow index
\(P_{{{\text{aCO}}_{2} }}\)
Arterial CO2 partial pressure
\(P_{{{\text{ECO}}_{2} }}\)
Exhaled CO2 pressure
PEEP
Positive end-expiratory pressure
PPV
Percentage of small-vessels perfused
TCD
Total capillary density
VA/Q
Ventilation-to-perfusion ratio
\(V_{{{\text{CO}}_{2} }}\)
CO2 production
VD/VT
Dead-space ventilation fraction
VE
Exhaled minute ventilation
VT
Tidal volume
VT/VRS
Driving pressure
Background
Acute respiratory distress syndrome (ARDS) is a form of acute respiratory failure characterized by pulmonary inflammation leading to increased capillary and epithelial permeability, with subsequent loss of aerated lung tissue and increased lung stiffness [1]. These alterations lead to imbalances between ventilation and perfusion relationships, which finally result in hypoxemia and impaired carbon dioxide clearance.
An optimal ventilation-to-perfusion (VA/Q) ratio (0.1 < VA/Q < 10) is necessary to ensure a normal gas exchange [2‐4]. Typically, it has been considered that pulmonary perfusion in ARDS occurs in non-ventilated (VA/Q < 0.005) or poorly ventilated (0.005 < VA/Q < 0.1) lung units, which, in turn, results in vasoconstriction of perfusing arterioles [5]. Such VA/Q mismatch in some lung regions in which perfusion largely exceeds ventilation, account for hypoxemia, which is the clinical hallmark of ARDS [1, 6, 7]. Nevertheless, distribution of ventilation to poorly perfused (10 < VA/Q < 100), severely hypoperfused (VA/Q > 100) or non-perfused (VA/Q ~ ∞) lung units might also occur in patients with ARDS [3] and indeed, increases in VD/VT have been strongly related with adverse clinical outcomes [8‐10]. Importantly, high VA/Q and VA/Q ~ ∞ ratios corresponding to lung regions where ventilation largely exceeds perfusion, account for carbon dioxide retention [5]. Increases in high VA/Q and/or dead-space lung units have been classically attributed to alveolar overdistention with the subsequent compression of intra-alveolar vessels in the non-dependent lung areas [8, 11]. Nevertheless, increased dead-space ventilation has also been described in patients subjected to protective ventilation strategies with low plateau pressures [9, 10], which suggest that mechanisms different to alveolar overdistention should be implied.
Anzeige
In normal conditions, the heterogeneity of systemic microcirculatory blood flow distribution is negligible [12]. Nevertheless, severe inflammation can induce microcirculatory alterations [13, 14] determining alterations in oxygen extraction capabilities by the tissues and contributing to the development of multiple organ dysfunction [14]. Although there are many technical limitations to directly evaluate pulmonary microcirculation [15], heterogeneity of microvascular blood flow at pulmonary level could contribute to imbalances between ventilation and perfusion relationships. Thus, considering microcirculatory dysfunction during inflammatory conditions as a generalized phenomenon, which may involve systemic and pulmonary vascular beds, we hypothesized that alterations in microvascular blood flow distribution evaluated at the sublingual mucosa as representative of an extra-pulmonary territory could be related to variations in dead-space ventilation VD/VT during early phases of moderate and severe ARDS.
Methods
This prospective observational study was conducted in a 90-bed mixed ICU from a university hospital. The local Ethical and Biomedical Research Committee approved the study (Fundación Valle del Lili EBRC protocol number: 0628; approval number: 038-7, 2013). A written informed consent was waived as no invasive procedures or new interventions were used. We daily screened all patients under mechanical ventilation in the ICU during a 24-month period, searching for those with moderate and severe ARDS. To avoid the selection of cases with transitory hypoxemia simulating ARDS, patients were enrolled only after successfully completing a two-step selection process [16, 17]: (a) first, patients mechanically ventilated through an endotracheal tube with a PEEP ≥ 5 and FiO2 ≥ 0.5 for at least 12 h and meeting the moderate and severe ARDS criteria according to Berlin Consensus definitions [1] were declared potentially eligible; (b) then, potential candidates were subjected to a FiO2 trial at 1.0 while maintaining PEEP ≥ 10 (to sustain a SpO2 ≥ 88%, but ensuring peak inspiratory and plateau pressures < 35 and 28 cmH2O, respectively) for at least 30 min, after which, new arterial blood gases were collected. Those patients maintaining a PaO2/FiO2 ≤ 200 after such PEEP/FiO2 trial and with < 48 h of evolution of ARDS were finally included. The exclusion criteria were: < 18 years of age, pregnancy state, history of neuromuscular diseases, moderate and severe COPD (defined as FEV1 < 80% predicted); history of intubation due to COPD exacerbation, receiving domiciliary oxygen or long-term use of steroids because COPD; history of congestive heart failure or any acute ischemic cardiac condition. A patient was also excluded when limitation of therapeutic effort orders were given.
Study protocol
After fulfilling the two-step selection process, patients selected were connected to a mainstream CO2 sensor and this in turn to a volumetric capnography module (Infinity EtCO2 + respiratory mechanics module, Dräger Medical Systems, Telford, USA). Mechanical ventilation parameters were adjusted after a stepwise alveolar recruitment maneuver, as it will be detailed later. After a 60 min of stabilization period, we started capnography measurements while sublingual microcirculatory images were simultaneously acquired, such as detailed thereafter. A new set of measurements was obtained 24 h after. Arterial and mixed venous blood samples (when available) were drawn for gases analysis (ABL300, Radiometer; Copenhagen, Denmark) at T0 and 24 h after (T24). In all the cases, the attending physicians decided on the type of hemodynamic monitoring to use. Complete respiratory and hemodynamic parameters were also registered simultaneously.
Recruitment maneuvers, PEEP adjustment and mechanical ventilation settings
At the time in which this study was performed, the local protocol included an initial recruitment maneuver to adjust PEEP in patients with severe ARDS. Thus, patients were subjected to a stepwise recruitment maneuver with progressive PEEP increases until a peak pressure of 50 cmH2O while maintaining a driving pressure of 15 cmH2O, as described elsewhere [18, 19]. Once obtained the maximal peak pressure, it was sustained during 2 min whereupon a decremental PEEP titration trial was conducted in steps of 2 cmH2O at 2 min interval from 22 to 8 cmH2O registering the corresponding compliance of the respiratory system (CRS). After such a PEEP titration, a new alveolar recruitment was performed until a peak pressure of 50 cmH2O while maintaining a driving pressure of 15 cmH2O during 1 min, to finally adjust the definitive ventilatory settings. Definitive PEEP was set at the corresponding best CRS plus 2 cmH2O. If falls in CRS were observed in two consecutive downsteps, then the PEEP level was set at the highest compliance plus 2 cmH2O. According to the local protocol, the recruitment maneuver was stopped if one or more of following signs were observed: heart rate > 150 or < 60 bpm; decrease of mean arterial pressure < 65 mmHg or systolic pressure < 90 mmHg; acute atrial fibrillation, atrial flutter or ventricular tachycardia.
Anzeige
Thereafter, mechanical ventilation was set in volume-controlled mode or in pressure-controlled, according to the selection of the attending physician. In the first case, ventilation was set at Vt of 6 ml/kg of predicted body weight maintaining plateau pressures < 28 cmH2O, flow of 60 l/min, inspiratory pause of 0.5 s, I:E ratio of 1:1 to 1:2, respiratory rate to match the minute ventilation previous to the recruitment maneuver, FiO2 necessary for SpO2 ≥ 90 and ≤ 95% and PEEP adjusted as indicated above. If plateau pressures were > 28 cmH2O, then Vt was reduced to a minimum of 4 ml/kg of predicted body weight. For those ventilated in pressure-controlled mode, driving pressure was adjusted to maintain Vt 6 ml/kg of predicted body weight (or less if Vt/CRS > 18), I:E ratio 1:1 to 1:2, minute ventilation matching that previous to the recruitment maneuver, peak inspiratory pressure ≤ 35 cmH2O, and FiO2 and PEEP adjusted as indicated above.
Pulmonary dead-space fraction measurements
After an automatic purge and calibration procedure, a mainstream CO2 sensor was placed between the ventilator circuit and the patient connection. This sensor was in turn connected to a volumetric capnography module (Infinity EtCO2 + respiratory mechanics module, Dräger Medical Systems, Telford, USA). After selection of the ventilator settings, a 60 min of stabilization period was allowed before to start the measurements. Data trend for CO2 production (\(V_{{{\text{CO}}_{2} }}\)) and exhaled minute ventilation (VE) were averaged over 5 min. \(V_{{{\text{CO}}_{2} }}\) measurements were obtained at standard temperature and pressure, and dry (STPD), whereby a correction factor of 0.863 mmHg l/ml was used to convert to body temperature, and pressure, saturated (BTPS). The fraction of exhaled CO2 (\(F_{{{\text{ECO}}_{2} }}\)) was calculated dividing the \(V_{{{\text{CO}}_{2} }}\) by the VE (Eq. 1):
Exhaled CO2 pressure (\(P_{{{\text{ECO}}_{2} }}\)) was then calculated as the product between the \(F_{{{\text{ECO}}_{2} }}\) and the barometric pressure minus the water vapor pressure (Eq. 2):
where PB corresponds to the local barometric pressure (i.e., 682 mmHg). Subsequently, VD/VT was calculated by the Enghoff modification of the Bohr equation (Eq. 3):
All measurements of \(V_{{{\text{CO}}_{2} }}\) performed by the module were automatically corrected for circuit compression, as described elsewhere [20].
Sublingual microcirculation assessment
A sidestream dark-field (SDF) imaging device (Micro Scan; MicroVision Medical, Amsterdam, the Netherlands) was used to explore the sublingual microcirculation simultaneously to dead-space fraction measurements, ventilatory mechanics and oxygenation parameters at both inclusion and 24 h after. A cutoff value of 20 μm was used to classify vessels as large or small. Continuous flows were considered as normal while intermittent and stopped flows were considered as abnormal. According to the consensus for the evaluation of microcirculation, we calculated the proportion of small vessels perfused (PPV), the total vascular density (TCD) and the functional capillary density (FCD) [21]. A heterogeneity index of microcirculatory blood flow was also calculated as the difference between maximal and minimal PPV values in five different mucosa areas divided by its own mean value (see Additional file 1). Additionally, we reported the microvascular flow index (MFI). A detailed description about microcirculatory blood flow assessment is provided in Additional file 1.
Statistical analysis
Sample size calculation is described in Additional file 1. Distribution of data was tested using the Kolmogorov–Smirnov test. Non-parametric test for related samples were used to evaluate the differences on hemodynamic, respiratory, capnometry and microcirculatory blood flow parameters between baseline and 24 h after. The relationships between the VD/VT, percentage of small vessels perfused (PPV), and microcirculatory blood flow index (MFI) were evaluated by the Spearman rho test. Other bivariate correlations between VD/VT, PaO2/FiO2, and respiratory mechanics were also performed using Spearman rho test. Additionally, simple linear regression models with linear and quadratic terms and their respective coefficients of determination (R2) were used to evaluate the relationship between each microcirculatory, respiratory mechanics or oxygenation parameter and the VD/VT at both baseline and 24 h after.
Finally, we calculated the delta of variation of VD/VT and PPV measurements between baseline and 24 h after. Then, a Spearman rho was used to evaluate the correlation between VD/VT and PPV dynamic variations from baseline to day-1. Furthermore, a simple linear regression model with quadratic term and its respective coefficient of determination (R2) was used to evaluate the relationship between variations in PPV and VD/VT from baseline to 24 h after. Data are presented as median [percentiles 25–75]. A p value ≤ 0.05 (2-tailed) was considered significant.
Results
A total of 42 patients with moderate and severe ARDS were included in the study. A complete flowchart detailing the selection process is shown in Additional file 1: Figure S1, while a STROBE statement checklist for observational studies is provided in Additional file 1: Table S1. Mortality at day-28 and day-90 were 31% and 45.2%, respectively. The ICU length of stay was 18.0 [11.8–26.3] days. General characteristics are presented in Table 1, while hemodynamics, respiratory mechanics, blood gases analysis, pulmonary dead-space fraction and microcirculatory blood flow parameters at baseline and 24 h after are presented in Table 2. We observed an inverse and significant relationship between PPV and VD/VT at both baseline (Spearman rho = − 0.76, p < 0.001; R2 = 0.63, p < 0.001) and 24 h after (Spearman rho = − 0.71, p < 0.001; R2 = 0.66, p < 0.001) (Fig. 1a, b). Similar findings were observed between VD/VT and the microcirculatory flow index at baseline (Spearman rho = − 0.63, p < 0.001; R2 = 0.48, p < 0.001) and 24 h after (Spearman rho = − 0.65, p < 0.001; R2 = 0.60, p < 0.001) (Fig. 1c, d). There were no significant correlations between VD/VT and other respiratory mechanics and oxygenation parameters (Fig. 2, Additional file 1: Table S2).
Table 1
General characteristics
All patients
Age
48 (33–63)
Sex, male (%)
24 (57.1)
APACHE II
21.5 (17.0 27.3)
SOFA, day 1
11.0 (7.8–13.3)
Coexisting conditions
Hypertension
8 (19.0)
Diabetes
5 (11.9)
Hepatic disease
5 (13.2)
Chronic renal failure
3 (7.3)
Cancer
6 (14.3)
Immunosuppression
6 (14.3)
BMI (kg/m2)
20.7 (20.3–22.7)
Risk factors for ARDS
Sepsis
28 (66.7)
Trauma
5 (13.2)
Pneumonia
13 (34.2)
Gastric aspiration
6 (15.8)
Other
11 (28.9)
Vasopressors, n (%)
26 (61.9)
Steroids, n (%)
15 (35.7)
TRR, n (%)
8 (19.5)
Prone position, n (%)
10 (23.8)
Muscular paralysis
34 (80.9)
Time since ICU admission to ARDS onset, hours
96 (24–168)
Cumulated resuscitation fluids, ml
2.300 (1.075–4.735)
Total cumulative fluids at ARDS diagnosis, ml
6.361 (2.182–13.023)
Mortality
At day 28
13 (31.0)
At day 90
19 (45.2)
Table 2
Hemodynamics, respiratory mechanics, blood gases analysis, \(V_{{{\text{CO}}_{2} }}\), VD/VT and microcirculatory parameters at baseline and 24 h after
Baseline
24 h
p
Hemodynamics
HR, bpm
104 (94–121)
100 (89–115)
0.43
MAP, mmHg
74 (69–87)
75 (67–92)
0.35
CVP, mmHg, n
12 (8–14)
12 (7–14)
0.96
PAOP, mmHg, n
14 (12–16), 22
19 (16–22), 24
0.03
PAPm, mmHg, n
36 (42–46), 22
30 (26–41), 24
0.13
PVR, dyn.s/cm5, n
298 (250–440), 22
299 (211–360), 24
0.86
Cardiac index, (l/min/m2), n
4.2 (3.4–4.5), 22
3.9 (3.5–4.4), 24
0.30
Norepinephrine, (ugr/kg/min), n
0.10 (0.05–0.27), 18
0.05 (0.03–0.34), 18
0.09
Respiratory mechanics and blood gases
VT, ml
369 (325–415)
363 (312–404)
0.56
VT, ml/kg
6.5 (6.1–6.9)
6.6 (6.4–6.9)
0.56
RR
24 (20–26)
25 (22–27)
0.17
PEEP
12 (10–15)
12 (10–14)
0.07
PPeak
30 (27–33)
29 (26–34)
0.57
Pmaw
19 (14–21)
18 (15–20)
0.36
VT/CRS
17 (14–19)
16 (14–18)
0.42
pH
7.28 (7.21–7.32)
7.35 (7.26–7.39)
< 0.001
PaO2, mmHg
79.1 (69.7–95.5)
86.6 (72.6–109.2)
0.06
PaCO2, mmHg
46.6 (39.9–56.3)
42.3 (34.6–47.6)
0.003
HCO3, mmol/L
20.9 (19.1–24.2)
20.7 (17.8–26.5)
0.78
BE, mmol/L
− 6.4 (− 8.8 to − 2.3)
− 5.9 (− 8.4 to − 0.05)
0.03
PaO2/FiO2
119 (93–148)
173 (124–222)
< 0.001
PvO2, mmHg
48.7 (42.3–54.1)
40.8 (36.9–47.6)
0.004
PvCO2, mmHg
48.2 (41.6–59.3)
44.6 (36.1–53.6)
0.003
ScvO2, %
78.0 (70.9–80.9)
75.2 (62.3–81.7)
0.17
Capnography/expired CO2
\(P_{{{\text{ECO}}_{2} }}\), mmHg (BTPS)
21.2 (18.4–24.6)
19.3 (14.8–21.6)
0.01
\(F_{{{\text{ECO}}_{2} }}\)
0.034 (0.029–0.039)
0.030 (0.023–0.034)
0.01
\(V_{{{\text{CO}}_{2} }}\), ml/min (STPD)
320 (250–405)
259 (201–380)
0.28
VTE, ml
372 (325–415)
302 (240–440)
0.39
VD/VT
54 (45–61)
51 (47–61)
0.44
Microcirculatory blood flow parameters
PPV, %
69.6 (57.8–79.2)
75.7 (62.8–81.5)
0.01
LVP, %
90.9 (82.3–96.5)
90.3 (85.3–96.8)
0.52
FCD, n vessels/mm2
6.6 (5.1–7.5)
6.9 (5.5–8.2)
0.03
TCD, n vessels/mm2
11.6 (10.8–12.6)
12.3 (11.0–13.3)
0.08
MFI
2.35 (2.08–2.50)
2.35 (2.20–2.60)
0.06
Heterogeneity index
0.38 (0.27–0.65)
0.28 (0.19–0.45)
0.08
HR: heart rate; MAP: mean arterial pressure; CVP: central venous pressure; PAOP: pulmonary artery occlusion pressure; PAPm: mean pulmonary artery pressure; PVR: pulmonary vascular resistance; VT: tidal volume; PEEP: positive end-expiratory pressure; PPeak: peak respiratory pressure; Pmaw: mean pressure of the airway; VT/CRS: tidal volume to respiratory system compliance (driving pressure); PaO2: arterial oxygen partial pressure; PaCO2: arterial carbon dioxide partial pressure; HCO3: bicarbonate; BE: base excess; PaO2/FiO2 ratio: arterial oxygen partial pressure to oxygen inspiratory fraction; PvO2: venous oxygen partial pressure; PvCO2: venous carbon dioxide partial pressure; SvO2: venous hemoglobin oxygen saturation; \(P_{{{\text{ECO}}_{2} }}\): exhaled carbon dioxide pressure; BTPS: body temperature, and pressure, saturated; STPD: standard temperature and pressure, dry; \(F_{{{\text{ECO}}_{2} }}\): exhaled carbon dioxide fraction; VTE: exhaled tidal volume; VD/VT: pulmonary dead-space fraction; PPV: percentage of small vessels perfused; LVP: percentage of large vessels perfused; FCD: functional capillary density; TCD: total capillary density; MFI: microvascular blood flow index
Fig. 1
Relationships between pulmonary dead-space fraction (VD/VT) and the microcirculatory blood flow at baseline and 24 h after. a Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the proportion of small vessels perfused at baseline. b Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the proportion of small vessels perfused 24 h after. c Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and MFI at baseline. d Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and MFI 24 h after. PPV: percentage of small vessels perfused; VD/VT: pulmonary dead-space fraction; HI: heterogeneity index of microcirculatory blood flow; MFI: microcirculatory blood flow index
Fig. 2
Relationships between pulmonary dead-space fraction (VD/VT) and some respiratory mechanics and oxygen parameters at baseline and 24 h after. a Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the PaO2/FiO2 ratio at baseline. b Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the PaO2/FiO2 ratio 24 h after. c Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and PEEP levels at baseline. d Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and PEEP levels 24 h after. e Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the VT/CRS at baseline. f Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and the VT/CRS 24 h after. g Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and Pmaw at baseline. h Scatter plot depicting the correlation between pulmonary dead-space fraction (VD/VT) and Pmaw 24 h after. PaO2/FiO2 ratio: arterial oxygen partial pressure to oxygen inspiratory fraction; PEEP: positive end-expiratory pressure; VT/CRS: tidal volume-to-respiratory system compliance ratio (i.e., driving pressure); Pmaw: mean pressure of the airway
×
×
Anzeige
A significant relationship was observed between the variation in VD/VT and the percentage of variation of PPV from baseline measurements to 24 h after (Spearman rho = − 0.66, p < 0.001; R2 = 0.67, p < 0.001) (Fig. 3, Additional file 1: Figure S2). Additional information about survivors and non-survivors at day-90 is provided in Additional file 1: Table S3.
Fig. 3
Relationships between dynamic variations in pulmonary dead-space fraction (VD/VT) and microcirculatory blood flow. Scatter plot depicting the correlation between variations in pulmonary dead-space fraction (Δ-VD/VT) vs. percentage of change in small vessels perfused (Δ-PPV) between baseline and 24 h after
×
Discussion
After simultaneous calculation of dead-space fraction by volumetric capnography and exploration of sublingual microcirculation by the SDF technique during the early stages of moderate and severe ARDS, we retrieved two hypothesis-generating observations: (a) VD/VT is inverse and significantly related with sublingual microcirculatory blood flow distribution, while PEEP levels, respiratory airway pressures, PaO2/FiO2 and lung strain surrogates (VT/CRS) do not; (b) VD/VT variations were closely related with dynamic changes in the microcirculatory blood flow distribution observed at sublingual mucosa.
Other mechanisms unrelated to shunt-induced hypoxemia could be implicated in gas exchange abnormalities and in the onset of pulmonary and extra-pulmonary multiorgan dysfunction in ARDS. Distribution of ventilation to poorly perfused (10 < VA/Q < 100), severely hypoperfused (VA/Q > 100) or non-perfused, i.e., true dead-space ventilation (VA/Q ~ ∞) lung units, can also contribute to gas exchange disturbances and it might be a key piece in the pathophysiology of ARDS. Some studies in the past demonstrated the occurrence of increased pulmonary dead-space fraction in patients with acute hypoxemic respiratory failure [3, 22, 23], and highlighted the apparent relationship between high VD/VT and increased mortality [8]. Nevertheless, early studies included patients under non-lung-protective ventilation strategies, in which over-inflation leading to capillary collapse could explain VA/Q mismatching with the resultant increased VD/VT [24]. Remarkably, later studies in ARDS patients subjected to lung-protective ventilation, also demonstrated the occurrence of increases in VD/VT and confirmed its consistent relationship with worse clinical outcomes [9, 10, 25]. In agreement with this, we observed increases in VD/VT at baseline and 24 h after in patients with moderate and severe ARDS. Importantly, we did not find any relationship between VD/VT and variables suggesting vascular collapse related to alveolar overdistention or increased pulmonary strain (e.g., VT/CRS), although admittedly, controlling airway pressures and VT/CRS (driving pressure) could not prevent alveolar overdistention because the inhomogeneous lung compromise in ARDS [26].
Relationships between microvascular blood flow and VD/VT have not been widely studied because of technical limitations to directly evaluate pulmonary microcirculation [15]. Our data suggest an apparent relationship between microcirculatory dysfunction and dead-space ventilation. Admittedly, sublingual mucosa and pulmonary circulation are two dissimilar vascular beds with particular regulating mechanisms. Nevertheless, during inflammatory conditions, microcirculatory dysfunction is a generalized phenomenon involving simultaneously most vascular beds [14], although with different effects depending on the territory studied [27]. Microcirculatory alterations have been described in autopsies and biopsies from lungs of patients with acute hypoxemic respiratory failure [28, 29] and angiograms performed through pulmonary artery catheters demonstrated filling defects attributable to macro- and micro-emboli [30, 31]. Increases in VD/VT in our patients were well correlated with alterations in microcirculatory blood flow distribution detected in a non-pulmonary vascular bed. Such observation could pose the hypothesis about heterogeneity of microvascular blood flow contributing to inequalities in VA/Q relationships. Indeed, variations of VD/VT from baseline to 24 h after were closely related with dynamic changes in microcirculatory blood flow distribution at sublingual mucosa, which reinforce the strength of such relation. Nevertheless, whether pulmonary microvascular alterations or other organ-specific microvascular blood flow can be evaluated or estimated through evaluation of an extra-pulmonary microvascular bed can result highly controversial [15].
Anzeige
In normal conditions, heterogeneity of microvascular blood flow is negligible [12] and matching of perfusion to metabolism usually improves during hypoxic or low-flow states [32]. However, during inflammatory conditions, heterogeneity of microcirculation increases as consequence of the interruption of blood flow of individual capillaries causing derangements in the oxygen extraction capabilities, thus contributing to organ failure. In agreement with this, we observed important microcirculatory alterations consisting in decreased PPV, reduced FCD and increased heterogeneity of blood flow, which were in turn linked to more severe extra-pulmonary organ dysfunction quantified by SOFA score (see Additional file 1: Table S3).
Pathophysiological mechanisms increasing VD/VT in ARDS are quite complex. An increased VD/VT reflects a global assessment of abnormal gas exchange, but not simply the contribution of discrete high VA/Q regions and true anatomic dead space (VA/Q ~ ∞). Although the patchy pattern of vascular damage is a phenomenon clearly recognized in ARDS [26], no studies demonstrated that damaged areas necessarily receive substantial ventilation, as would be necessary to explain regions of high VA/Q ratio. Using the multiple inert gas elimination technique (MIGET) to evaluate the fractional contribution of each VA/Q abnormality (shunt, mid-range VA/Q heterogeneity, high VA/Q, and anatomic dead space) on total VD/VT at progressively high PEEP levels, Coffey et al. [33] demonstrated similar VD/VT values at different PEEP levels mediated by very different physiologic abnormalities, although certainly, higher PEEP values were consistently related to high VA/Q peaks. Our results might add more complexity to the pathophysiology on increased VD/VT in ARDS suggesting the contribution of altered microcirculatory blood flow distribution on the increase of high VA/Q units.
Routine assessment of pulmonary gas exchange in ARDS is based on analysis of oxygen and carbon dioxide partial pressures. These variables, although sensitive to intrapulmonary factors (e.g., shunt and VA/Q matching), could be also altered by extra-pulmonary elements such as cardiac output, oxygen consumption, minute ventilation and inspired oxygen fraction.
VD/VT values can widely vary according to the method used to estimate it [34]. Previous studies used the Enghoff modification of the Bohr equation (VDEnghoff) in patients with ARDS [8‐10, 25]. Nevertheless, this method could overestimate the real VD/VT when anatomic or intrapulmonary shunts are present as it assumes a perfect VA/Q matching throughout all alveolar–capillary units [35, 36]. Although we used the VDEnghoff method, we computed VD/VT from the CO2 production (\(V_{{{\text{CO}}_{2} }}\)) and CO2 exhaled fraction (\(F_{{{\text{ECO}}_{2} }}\)) measurements by volumetric capnography, which can accurately reflect measurements by metabolic monitors [20].
Anzeige
Trying to exclude cases with transitory hypoxemia simulating ARDS, we completed a two-step selection previously described [16, 17]. Although breathing pure oxygen may influence the VA/Q distribution [5], our definitive VD/VT measurements were performed 60 min after return to the previous FiO2, thus causing the lowest impact on VA/Q balance. Also, we used a stepwise recruitment maneuver with progressive PEEP increases, which was part of the local protocol at the time in which patients were included. Probably at present, such maneuver would not be used as recent evidence suggests that it can be harmful [37]. Nevertheless, such maneuver allowed us to standardize the selection of PEEP and ventilatory parameters.
We recognize that our study has important limitations. First, many hemodynamic and respiratory coexisting factors can influence VD/VT measurements. Indeed, combination of hypovolemia, vasoactive agents and/or inotropics, cardiac output variations, pulmonary resistances and flows, distribution of ventilation along the lungs and even local microthrombi formation, might influence VD/VT variations in one or other direction. Thereby, identical VD/VT elevations might reflect simultaneous alterations in diverse physiological components. Second, our study is not able to demonstrate a causal association between VD/VT and sublingual microcirculation and it was not registered as observational study. Nevertheless, dynamic variations from baseline to 24 h after merit exploration in future studies. Third, whether pulmonary microvascular alterations occur in parallel to other extra-pulmonary microvascular beds is highly controversial. However, microcirculation studies reveal simultaneous alterations at different beds during shock or inflammatory conditions. Fourth, the number of cases included in our study was relatively small. However, the fact that our patients were strictly selected and calculation of VD/VT used \(V_{{{\text{CO}}_{2} }}\) and exhaled fraction of CO2 (\(F_{{{\text{ECO}}_{2} }}\)) measurements by volumetric capnography strengthens our results.
Conclusion
Increased heterogeneity of microcirculatory blood flow evaluated at sublingual mucosa seems to be related to increases in VD/VT independently of respiratory mechanics and oxygen parameters, thus suggesting that microcirculatory alterations could be implicated in ventilation/perfusion mismatching during early ARDS.
The inverse dynamic relationships observed between sublingual microcirculation and dead-space ventilation poses a hypothetical pathophysiological mechanism during moderate and severe ARDS that deserves future research efforts.
The authors thank Dr. Fernando Rosso (CIC, Fundación Valle del Lili-Universidad Icesi, Cali, Colombia) and Dr. Yuri Takeuchi (Universidad Icesi - Fundación Valle del Lili) for their unconditional support to this project.
Ethics approval and consent to participate
The ethical and research committee involving human beings approved the current study (Protocol number: 0628; Approval Number: 038-7, 2013, Fundación Valle del Lili, Cali, Colombia).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Microcirculatory dysfunction and dead-space ventilation in early ARDS: a hypothesis-generating observational study
verfasst von
Gustavo A. Ospina-Tascón Diego F. Bautista Humberto J. Madriñán Juan D. Valencia William F. Bermúdez Edgardo Quiñones Luis Eduardo Calderón-Tapia Glenn Hernandez Alejandro Bruhn Daniel De Backer
